Oral Steroids for the Resolution of Otitis Media with Effusion (OME) in Children (OSTRICH): study protocol for a randomised controlled trial

Waldron, Cherry-Ann ORCID: https://orcid.org/0000-0001-8465-2492, Thomas-Jones, Emma ORCID: https://orcid.org/0000-0001-7716-2786, Cannings-John, Rebecca ORCID: https://orcid.org/0000-0001-5235-6517, Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Powell, Colin, Roberts, Amanda, Tomkinson, Alun, Fitzsimmons, Deborah, Gal, Micaela ORCID: https://orcid.org/0000-0002-1326-190X, Harris, Debbie ORCID: https://orcid.org/0000-0002-7073-7724, Shepherd, Victoria ORCID: https://orcid.org/0000-0002-7687-0817, Butler, Christopher ORCID: https://orcid.org/0000-0002-0102-3453 and Francis, Nicholas ORCID: https://orcid.org/0000-0001-8939-7312 2016. Oral Steroids for the Resolution of Otitis Media with Effusion (OME) in Children (OSTRICH): study protocol for a randomised controlled trial. Trials 17 , 115. 10.1186/s13063-016-1236-1

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (831kB) | Preview

Abstract

Background Otitis media with effusion (OME) is an accumulation of fluid in the middle ear affecting about 80% of children by the age of 4 years. While OME usually resolves spontaneously, it can affect speech, behaviour and development. Children with persistent hearing loss associated with OME are usually offered hearing aids or insertion of ventilation tubes through the tympanic membrane. Oral steroids may be a safe and effective treatment for OME, which could be delivered in primary care. It has the potential to benefit large numbers of children and reduce the burden of care on them and on health services. However, previous trials have either been too small with too short a follow up period, or of too poor quality to give a definite answer. The aim of the OSTRICH trial is to determine if a short course of oral steroids improves the hearing of children with OME in the short and longer term. Methods/Design 380 participants (children aged 2-8 years) are recruited from Hospital Ear, Nose and Throat departments in Wales and England. A trained clinician seeks informed consent from parents of children with symptoms attributable to OME for at least 3 months and with confirmed bilateral hearing loss at study entry. Participants are randomised to a course of oral steroid or a matched placebo for one week. Outcomes include audiometry, tympanometry and otoscopy assessments, symptoms, adverse effects, functional health status, quality of life, resource use and cost effectiveness. Participants are followed up at 5 weeks, and at 6 and 12 months after the day of randomisation. The primary outcome is audiometry-confirmed satisfactory hearing at 5 weeks. Discussion There is an important evidence gap regarding clinical and cost effectiveness of short courses of oral steroid treatment for OME. Identifying an effective, safe, non-surgical intervention for OME in children for use in primary care would be of great benefit to children, their families and the NHS.

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General) R Medicine > RJ Pediatrics
Publisher:	BioMed Central
ISSN:	1745-6215
Funders:	NIHR HTA Programme
Date of First Compliant Deposit:	30 March 2016
Date of Acceptance:	17 February 2016
Last Modified:	11 Oct 2023 20:44
URI:	https://orca.cardiff.ac.uk/id/eprint/86893

Citation Data

Cited 10 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item